Acetylsalicylic acid Active Not Recruiting Phase 4 Trials for Coronary Heart Disease (CHD) / Percutaneous Transluminal Coronary Angioplasty Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02939872Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events